Trial reportBMC psychiatry2025
Longitudinal changes in sleep quality in male patients with alcohol dependence receiving far-infrared ray therapy: associations with alterations in circulating pro-inflammatory cytokines.
Trial report in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveSleep disturbance is common in alcohol dependence (AD). Far-infrared ray (FIR) therapy has anti-inflammatory properties and may improve sleep, offering a potential non-pharmacological treatment during withdrawal. The primary objective of this study was to compare sleep quality and serum pro-inflammatory cytokine levels between AD patients who received FIR therapy and those who received standard care only.
methodsA total of 114 male AD patients who completed a two-week withdrawal program were randomized to a control group (n = 61) receiving supportive care, or a treatment group (n = 53) receiving supportive care plus five FIR sessions. Sleep quality was assessed using cardiopulmonary coupling (CPC), and serum levels of 10 cytokines were measured via Luminex assay before and after the intervention. Analysis of covariance (ANCOVA) compared post-treatment outcomes between groups, controlling for baseline values. Pearson correlation analysis examined relationships between changes in sleep parameters and cytokine levels.
resultsCompared to controls, the treatment group showed significantly increased total sleep time and sleep efficiency. Moreover, serum levels of IL-1β, IL-6, and TNF-α were significantly reduced in the treatment group. Addtionally, improvements in total sleep time and sleep efficiency were negatively correlated with changes in IL-1β and TNF-α levels.
conclusionsFIR therapy may improve sleep quality and reduce pro-inflammatory cytokines in AD patients during withdrawal, suggesting its potential as an alternative to hypnotic medications for sleep management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.